Mary Smith
Director/Miembro de la Junta en ENDO INTERNATIONAL PLC .
Perfil
Mary Christine Smith is currently an Independent Director at Endo International Plc and the Head-Talent, Organization & Human Potential at Accenture Plc.
Previously, she served as the Global Vice President-Inclusion & Diversity at Apple, Inc. from 2017 to 2020 and as the Regional Managing Partner at Deloitte & Touche LLP from 2001 to 2017.
Dr. Smith holds a graduate degree from Rutgers State University of New Jersey, an undergraduate degree from Loyola University Maryland, Inc., and a doctorate degree from New York University.
Cargos activos de Mary Smith
Empresas | Cargo | Inicio |
---|---|---|
ENDO INTERNATIONAL PLC | Director/Miembro de la Junta | 29/07/2020 |
ACCENTURE PLC | Oficial de Recursos Humanos | - |
Antiguos cargos conocidos de Mary Smith.
Empresas | Cargo | Fin |
---|---|---|
APPLE INC. | Corporate Officer/Principal | 01/01/2020 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2017 |
Formación de Mary Smith.
Loyola University Maryland, Inc. | Undergraduate Degree |
Rutgers State University of New Jersey | Graduate Degree |
New York University | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
APPLE INC. | Electronic Technology |
ACCENTURE PLC | Technology Services |
Empresas privadas | 2 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
- Bolsa de valores
- Insiders
- Mary Smith